Advertisement
Screener

ASTEX PHARMACEUTICALS, INC Forms 3, 4 and 5: Other

ASTEX PHARMACEUTICALS, INC Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2011-07-22: Reporting owner Kola Ismail; Form 3; Security No securities beneficially owned; Transaction Holding.
  • 2011-07-22: Reporting owner Jhoti Harren; Form 3; Security No securities beneficially owned; Transaction Holding.
  • 2011-07-22: Reporting owner Haines Timothy; Form 3; Security No securities beneficially owned; Transaction Holding.
  • 2011-07-22: Reporting owner Fellner Peter; Form 3; Security No securities beneficially owned; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2011-07-22
holding as of filing
Kola Ismail
Director
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2011-07-22
2011-07-22
holding as of filing
Jhoti Harren
Director, Officer (President)
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2011-07-22
2011-07-22
holding as of filing
Haines Timothy
Director
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2011-07-22
2011-07-22
holding as of filing
Fellner Peter
Director
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2011-07-22
2011-07-22
holding as of filing
Buckland Martin
Officer (Chief Business Officer)
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2011-07-22
2007-05-30
holding as of filing
Berk Gregory
Officer (Chief Medical Officer)
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2007-05-30